Generate a tailored SOP for Dr. Raimar Loebenberg. Improve your application with a focused, well-structured draft.
Dr. Loebenberg holds a BSc in Pharmacy from Johannes Gutenberg-University Mainz, Germany, and received his PhD in Pharmaceutics from Johann Wolfgang Goethe-University Frankfurt in 1996. He joined the University of Alberta in 2000, where he has established himself as a prominent researcher in biopharmaceutics, focusing on oral drug performance prediction, particularly in relation to botanicals and inhalable nanoparticles for treating lung diseases. He is the founder and director of the Drug Development Innovation Centre at the University of Alberta and has served as president of the Canadian Society for Pharmaceutical Sciences in 2014 and 2015. His extensive research contributions include numerous publications, presentations, and patents in the field of Pharmaceutical Sciences. He has been actively involved in translational research to develop modern Natural Health Products and has conducted clinical trials for various dosage forms. His research is not only published in high-impact journals but also recognized through awards like the American College of Clinical Pharmacology New Investigator Award. Currently, his work encompasses advanced drug formulation methods, including lysosomal trapping for targeted drug delivery and innovations in medical cannabis formulations, positioning him as a leader in modern pharmacological research.
Drug Development Innovation Centre, University of Alberta • Edmonton, AB
Founded and directed the Drug Development Innovation Centre focusing on biopharmaceutical research and innovation.
Department: Mechanical Engineering and Engineering Management